A woman's decades-long struggle with incontinence was finally solved when doctors discovered a rare condition.

The first new antibiotic for UTIs in nearly 30 years has been approved by regulators. Gepotidacin, also known as Blujepa, is ...

Relmada Therapeutics Inc ($RLMD) announced an update on their ongoing clinical study. Relmada Therapeutics is preparing to launch a late-stage ...

Report OverviewThe global botulinum toxin market is entering a phase of sustained expansion, with growth propelled by rising demand in both aesthetic and therapeutic domains. As a neurotoxin derived ...

While people swear by their favorite home remedies, most—including the three described above—remain unproved. Every now and then, however, a piece of folklore is scientifically validated. Sometimes ...

Retired Middletown dentist Doug Brockman and his wife, Beth, realized a 30-year-old dream by completing one of the world’s ...

There are even tripod screws on both the side and bottom of the unit, enabling you to mount the Handy 2 to any compatible ...

This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...

In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs ...

CystoSmart™, an AI software tool for bladder tumor detection in patients undergoing screening and surveillance endoscopic examination of the bladder is brand agnostic and compatible with flexible and ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

Abbott’s Volt pulsed field ablation system — for the treatment of atrial fibrillation. The Volt system delivers high-energy electrical pulses to targeted areas of the heart to disrupt abnormal rhythms ...